SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cell Source, Inc. – ‘10-Q’ for 3/31/21 – ‘EXCEL’

On:  Monday, 5/17/21, at 5:25pm ET   ·   For:  3/31/21   ·   Accession #:  1493152-21-11971   ·   File #:  0-55413

Previous ‘10-Q’:  ‘10-Q’ on 11/13/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/12/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/17/21  Cell Source, Inc.                 10-Q        3/31/21   41:2.1M                                   M2 Compliance LLC/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    187K 
 2: EX-31       Certification -- §302 - SOA'02                      HTML     19K 
 3: EX-32       Certification -- §906 - SOA'02                      HTML     14K 
10: R1          Document and Entity Information                     HTML     42K 
11: R2          Condensed Consolidated Balance Sheets               HTML    101K 
12: R3          Condensed Consolidated Balance Sheets               HTML     39K 
                (Parenthetical)                                                  
13: R4          Condensed Consolidated Statements of Operations     HTML     66K 
14: R5          Condensed Consolidated Statements of Changes In     HTML     99K 
                Stockholders' Deficiency (Unaudited)                             
15: R6          Condensed Consolidated Statements of Cash Flows     HTML    121K 
16: R7          Business Organization, Nature of Operations, Risks  HTML     22K 
                and Uncertainties and Basis of Presentation                      
17: R8          Going Concern and Management Plans                  HTML     18K 
18: R9          Summary of Significant Accounting Policies          HTML     22K 
19: R10         Fair Value                                          HTML     28K 
20: R11         Notes Payable                                       HTML     26K 
21: R12         Stockholders' Deficiency                            HTML     24K 
22: R13         Related Party Transactions                          HTML     17K 
23: R14         Commitments and Contingencies                       HTML     22K 
24: R15         Subsequent Events                                   HTML     18K 
25: R16         Summary of Significant Accounting Policies          HTML     22K 
                (Policies)                                                       
26: R17         Summary of Significant Accounting Policies          HTML     20K 
                (Tables)                                                         
27: R18         Fair Value (Tables)                                 HTML     28K 
28: R19         Going Concern and Management Plans (Detail          HTML     32K 
                Narrative)                                                       
29: R20         Summary of Significant Accounting Policies (Detail  HTML     19K 
                Narrative)                                                       
30: R21         Summary of Significant Accounting Policies -        HTML     22K 
                Schedule of Weighted Average Dilutive Common                     
                Shares Anti-dilutive (Details)                                   
31: R22         Fair Value (Details Narrative)                      HTML     17K 
32: R23         Fair value - Schedule of Changes In Fair Value of   HTML     27K 
                Liabilities Measured at Fair Value on Recurring                  
                Basis (Details)                                                  
33: R24         Fair Value - Schedule of Valuation of Level 3       HTML     25K 
                Liabilities (Details)                                            
34: R25         Notes Payable (Details Narrative)                   HTML     96K 
35: R26         Stockholders' Deficiency (Details Narrative)        HTML     76K 
36: R27         Related Party Transactions (Details Narrative)      HTML     24K 
37: R28         Commitments and Contingencies (Details Narrative)   HTML     34K 
38: R29         Subsequent Events (Details Narrative)               HTML     47K 
40: XML         IDEA XML File -- Filing Summary                      XML     69K 
39: EXCEL       IDEA Workbook of Financial Reports                  XLSX     46K 
 4: EX-101.INS  XBRL Instance -- clcs-20210331                       XML    512K 
 6: EX-101.CAL  XBRL Calculations -- clcs-20210331_cal               XML    106K 
 7: EX-101.DEF  XBRL Definitions -- clcs-20210331_def                XML    286K 
 8: EX-101.LAB  XBRL Labels -- clcs-20210331_lab                     XML    565K 
 9: EX-101.PRE  XBRL Presentations -- clcs-20210331_pre              XML    427K 
 5: EX-101.SCH  XBRL Schema -- clcs-20210331                         XSD     81K 
41: ZIP         XBRL Zipped Folder -- 0001493152-21-011971-xbrl      Zip     63K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook

Top
Filing Submission 0001493152-21-011971   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 8:46:42.1am ET